Successful ceftolozane-tazobactam rescue therapy in a child with endocarditis caused by multidrug-resistant Pseudomonas aeruginosa. 2019

María Martín-Cazaña, and Santiago Grau, and Cristina Epalza, and Patricia Brañas, and Marta Flores, and Marta Olmedilla, and Daniel Blázquez-Gamero
Department of Pediatrics, Complutense University of Madrid, Madrid, Spain.

UI MeSH Term Description Entries
D008297 Male Males
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004697 Endocarditis, Bacterial Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use. Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078142 Tazobactam A penicillanic acid and sulfone derivative and potent BETA-LACTAMASE inhibitor that enhances the activity of other anti-bacterial agents against beta-lactamase producing bacteria. Tazobactam Sodium,YTR 830,YTR 830H,YTR-830,YTR830
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

María Martín-Cazaña, and Santiago Grau, and Cristina Epalza, and Patricia Brañas, and Marta Flores, and Marta Olmedilla, and Daniel Blázquez-Gamero
February 2017, Infection,
María Martín-Cazaña, and Santiago Grau, and Cristina Epalza, and Patricia Brañas, and Marta Flores, and Marta Olmedilla, and Daniel Blázquez-Gamero
March 2017, Antimicrobial agents and chemotherapy,
María Martín-Cazaña, and Santiago Grau, and Cristina Epalza, and Patricia Brañas, and Marta Flores, and Marta Olmedilla, and Daniel Blázquez-Gamero
March 2017, BMJ case reports,
María Martín-Cazaña, and Santiago Grau, and Cristina Epalza, and Patricia Brañas, and Marta Flores, and Marta Olmedilla, and Daniel Blázquez-Gamero
October 2016, Pharmacotherapy,
María Martín-Cazaña, and Santiago Grau, and Cristina Epalza, and Patricia Brañas, and Marta Flores, and Marta Olmedilla, and Daniel Blázquez-Gamero
September 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
María Martín-Cazaña, and Santiago Grau, and Cristina Epalza, and Patricia Brañas, and Marta Flores, and Marta Olmedilla, and Daniel Blázquez-Gamero
May 2020, The Pediatric infectious disease journal,
María Martín-Cazaña, and Santiago Grau, and Cristina Epalza, and Patricia Brañas, and Marta Flores, and Marta Olmedilla, and Daniel Blázquez-Gamero
May 2023, The new microbiologica,
María Martín-Cazaña, and Santiago Grau, and Cristina Epalza, and Patricia Brañas, and Marta Flores, and Marta Olmedilla, and Daniel Blázquez-Gamero
October 2019, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,
María Martín-Cazaña, and Santiago Grau, and Cristina Epalza, and Patricia Brañas, and Marta Flores, and Marta Olmedilla, and Daniel Blázquez-Gamero
November 2020, Open forum infectious diseases,
María Martín-Cazaña, and Santiago Grau, and Cristina Epalza, and Patricia Brañas, and Marta Flores, and Marta Olmedilla, and Daniel Blázquez-Gamero
December 2020, Microorganisms,
Copied contents to your clipboard!